IllumiNeuro Protocol record · updated 18h ago

Neuro & moodSleep & circadianGrade B · human evidenceResearch use only

All 6 studies Jump to the evidence Compare

What is IllumiNeuro Protocol used for?

IllumiNeuro Protocol is a cognitive enhancement blend consisting of four peptides, primarily focusing on nootropic and neurotrophic effects. The peptides included in this protocol are Selank and Semax, which have been studied for their potential to improve memory, focus, and neuroprotection. The mechanisms of action for these peptides involve modulation of neurotransmitter systems, neuroinflammation, and neurogenesis, which may contribute to their cognitive-enhancing properties.

Primarily researched for · Neuro & mood

Development stage

where IllumiNeuro Protocol sits between preclinical work and regulatory approval

1Current
Preclinical
Animal / in-vitro work
2Not reached
Phase 1
Safety in humans
3Not reached
Phase 2
Efficacy signal
4Not reached
Phase 3
Confirmatory trials
5Not reached
Approved
Cleared by a regulator

Stage is inferred from the highest trial phase in the indexed corpus. It describes the research record, not a recommendation.

Identity

NameIllumiNeuro Protocol

Chain length—

Molecular weight—

Formula—

Structure type—

ClassCognitive

Research levelLimited Research

Discovered byCurated master list · 2026

Pharmacology

Mechanism—

Route—

Half-life—

Time to peak—

Duration—

Extraction confidence—

Effect profile · 0–5

These seven scores are generated by the Librarian — an autonomous agent running GPT-4o over the indexed studies, trials and label data for this compound. No human assigns them and no community vote moves them. Last recomputed Jul 27, 2026. How this works →

Research stats

Total studies6

Human / animal / cellular1 / 3 / 0

Highest trial phasePreclinical

Years covered2010–2021

Latest study3mo ago

Publication history

20102021

Research funding

—no NIH grants found

Safety signals

FAERS reportsnone recorded

Serious AEs in animal work—

Community reports—

Positive —Neutral —Negative —

Records

ChEMBL ClinicalTrials.gov DrugBank Google Scholar PubChem PubMed · 6 Semantic Scholar UniProt

Study register

6 rowsOpen in the library →

SortDate added ↓Publication year Evidence type Summary depth

Study	Type	Year	Summary depth
Functional Connectomic Approach to Studying Selank and Semax Effects. FindingNot reported in abstract.	Human	2020	Full text read0.70
The Influence of Selank on the Level of Cytokines Under the Conditions of "Social" Stress. FindingSelank treatment led to a decrease in IL-1β and IL-6 concentrations, reaching control values.	Animal	2021	Full text read0.70
The Influence of Selank on the Level of Cytokines Under the Conditions of "Social" Stress. FindingStatistically significant increase in IL-1β and IL-6 in stressed rats, p<0.05.	Animal	2021	Full text read0.70
When an obscurity becomes trend: social-media descriptions of tianeptine use and associated atypical drug use. Finding78.9% interrater agreement from 1,090 concordant codes out of 1,382 unique codes.	review	2021	Full text read0.70
Antistress Action of Melanocortin Derivatives Associated with Correction of Gene Expression Patterns in the Hippocampus of Male Rats Following Acute Stress. Finding1359 differentially expressed genes (DEGs) identified in vehicle-treated rats subjected to ARS, cutoff >1.5 fold change, Padj < 0.05.	Animal	2021	Full text read0.70
"Brain doping" substances: prohibited or not in sports? FindingNot reported in abstract.	review	2010	Full text read0.70

What people are saying

anecdotal · not evidence

Unverified first-hand accounts from public forums. These are not studies: nobody checked what was taken, whether it was what the label said, or what else was going on. They count for nothing in the evidence grade above and are shown because a reader searching IllumiNeuro Protocol will meet them anyway, and meeting them next to a graded evidence base is better than meeting them alone.

Community collection has not run yet, so this is an empty shelf rather than a quiet one — nothing has been read, and no conclusion about how much IllumiNeuro Protocol is discussed should be drawn from it.